@techcrunch.com 2 years ago
Rani Therapeutics’ $73M IPO will fund upcoming clinical trials
@techcrunch.com 5 years ago
Public shareholders got high today on Tilray, the first marijuana company to IPO on Nasdaq
@techcrunch.com 8 years ago
Editas biotech stock drops by 26% over CRISPR patent dispute